GlobalData Healthcare

All articles by GlobalData Healthcare

1. Illegal online pharmacies: How endemic are they?

   Illegal pharmacies are defined as those that operate without certification, prescribe drugs without adhering to legal guidelines, or knowingly distribute…
   Read More…

   20 Jul
2. Population boom will boost acute stroke market, particularly in China

   The acute ischemic stroke (AIS) market is about to experience growth across the eight major markets (the 8MM: US, France,…
   Read More…

   18 Jul
3. Epilepsy: Zogenix’s ZX008 set for showdown with GW Pharma’s Epidiolex

   On July 12, Zogenix announced the positive results for its drug ZX008 (fenfluramine hydrochloride) in the treatment of young children…
   Read More…

   18 Jul
4. Head-to-head: competing for the most effective psoriasis drug

   The psoriasis drug market is a highly competitive market and the first major biologics that were released were anti-tumour necrosis…
   Read More…

   17 Jul
5. Takeda to seek label expansion for Ninlaro in multiple myeloma

   On July 11, Takeda announced positive results from the pivotal Phase III TOURMALINE-MM3 study that will be used to support…
   Read More…

   17 Jul
6. Does Type 2 diabetes increase the risk of Parkinson’s disease?

   Parkinson’s disease (PD) is the second most common chronic progressive neurodegenerative disorder in the elderly after Alzheimer’s disease, affecting 1–2%…
   Read More…

   13 Jul
7. Pfizer price hikes: do rare cancer drugs warrant higher prices?

   Last week, it was revealed that pharmaceutical giant Pfizer conducted its second round of US drug price hikes this year…
   Read More…

   11 Jul
8. CAR-T: how will these $400k therapies be adapted for Europe?

   The CAR-T era is already well underway in the US, with Novartis’ Kymriah (tisagenlecleucel) and Gilead’s Yescarta (axicabtagene ciloleucel) already…
   Read More…

   10 Jul
9. The stem cell pipeline for cardiovascular and metabolic disorders

   Regenerative medicine could potentially cure diseases and replace palliative treatments for chronic diseases such as heart failure or diabetes. Stem…
   Read More…

   10 Jul
10. FDA removes key barrier to US biosimilar development

    On June 21, the FDA withdrew draft guidance for industry entitled ‘Statistical Approaches to Evaluate Analytical Similarity.’ The guidance, issued…
    Read More…

    10 Jul